A new analysis finds that most pregnant patients with depression or anxiety discontinue SSRIs/SNRIs—and face nearly double the risk of mental health emergencies.
Kelly B. Zafman, MD, MSCR
Advertisement
Zafman is a maternal-fetal medicine fellow at the Hospital of the University of Pennsylvania.
Articles by Kelly B. Zafman, MD, MSCR
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Rose Molina, MD, discusses equitable ob-gyn care for immigrants at SMFM 2026
2
Christina Paidas Teefey, MD, on earlier fetal diagnosing and future psychosocial support
3
FDA updates labels on multiple menopausal hormone therapies
4
FDA approves changes to iPLEDGE REMS to reduce burden during use of isotretinoin
5